Browsing byAuthorYakkundi, A

Jump to a point in the index:
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
2020-02-04FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancerAnnett, S; Moore, G; Short, A; Marshall, A; McCrudden, C; Yakkundi, A; Das, S; McCluggage, WG; Nelson, L; Harley, I; Moustafa, N; Kennedy, CJ; deFazio, A; Brand, A; Sharma, R; Brennan, D; O’Toole, S; O’Leary, J; Bates, M; O’Riain, C; O’Connor, D; Furlong, F; McCarthy, H; Kissenpfennig, A; McClements, L; Robson, T
2019-04-11FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4McClements, L; Annett, S; Yakkundi, A; O'Rourke, M; Valentine, A; Moustafa, N; Alqudah, A; Simões, BM; Furlong, F; Short, A; McIntosh, SA; McCarthy, HO; Clarke, RB; Robson, T
2015-01-01FKBPL: A marker of good prognosis in breast cancerNelson, L; McKeen, HD; Marshall, A; Mulrane, L; Starczynski, J; Storr, SJ; Lanigan, F; Byrne, C; Arthur, K; Hegarty, S; Ali, AA; Furlong, F; McCarthy, HO; Ellis, IO; Green, AR; Rakha, E; Young, L; Kunkler, I; Thomas, J; Jack, W; Cameron, D; Jirström, K; Yakkundi, A; McClements, L; Martin, SG; Gallagher, WM; Dunn, J; Bartlett, J; O'Connor, D; Robson, T
2015-01-01FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesisYakkundi, A; Bennett, R; Hernández-Negrete, I; Delalande, JM; Hanna, M; Lyubomska, O; Arthur, K; Short, A; McKeen, H; Nelson, L; McCrudden, CM; McNally, R; McClements, L; McCarthy, HO; Burns, AJ; Bicknell, R; Kissenpfennig, A; Robson, T
2013-02-15The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal PathwayYakkundi, A; McCallum, L; O'Kane, A; Dyer, H; Worthington, J; McKeen, HD; McClements, L; Elliott, C; McCarthy, HO; Hirst, DG; Robson, T